What type of study is this?

This is a Pre-Registered Trial study.

December 8, 2025BloodOpen Access

Experience with minor surgeries in people with hemophilia A or B with and without inhibitors receiving fitusiran

View Full Paper

Ask AI

Bookmark

Excellent hemostatic control was achieved in 95% of minor surgeries conducted in hemophilia patients on fitusiran.
71 minor surgeries were performed across various types, with only 1 rated moderate on the hemostatic control scale.
Assessment used the ISTH 4-point response scale, highlighting the effectiveness of perioperative management.
Overall, fitusiran allows for safer surgical procedures in hemophilia patients without requiring extensive antifibrinolytic use.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational analysis shows effective hemostasis in 95% of minor surgeries for hemophilia A and B patients on fitusiran, indicating improved perioperative management.

Cite This Study

You et al. (2025) studied this question.

synapsesocial.com/papers/69362f6e4fa91c937236e11a https://doi.org/10.1182/blood-2025-4850

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis shows effective hemostasis in 95% of minor surgeries for hemophilia A and B patients on fitusiran, indicating improved perioperative management.

Experience with minor surgeries in people with hemophilia A or B with and without inhibitors receiving fitusiran

Key Points

Discussion

Implication

Cite This Study

Experience with minor surgeries in people with hemophilia A or B with and without inhibitors receiving fitusiran

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider